IBDEI07Y ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3568,1,5,0)
 ;;=5^Uncertain Behavior Neo Skin
 ;;^UTILITY(U,$J,358.3,3568,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,3569,0)
 ;;=239.2^^31^303^4
 ;;^UTILITY(U,$J,358.3,3569,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3569,1,2,0)
 ;;=2^239.2
 ;;^UTILITY(U,$J,358.3,3569,1,5,0)
 ;;=5^Unspecified Neoplasm
 ;;^UTILITY(U,$J,358.3,3569,2)
 ;;=^267783
 ;;^UTILITY(U,$J,358.3,3570,0)
 ;;=V76.43^^31^303^2
 ;;^UTILITY(U,$J,358.3,3570,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3570,1,2,0)
 ;;=2^V76.43
 ;;^UTILITY(U,$J,358.3,3570,1,5,0)
 ;;=5^Screening for malignant neoplasm
 ;;^UTILITY(U,$J,358.3,3570,2)
 ;;=^295657
 ;;^UTILITY(U,$J,358.3,3571,0)
 ;;=698.3^^31^304^2
 ;;^UTILITY(U,$J,358.3,3571,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3571,1,2,0)
 ;;=2^698.3
 ;;^UTILITY(U,$J,358.3,3571,1,5,0)
 ;;=5^Prurigo Nodularis
 ;;^UTILITY(U,$J,358.3,3571,2)
 ;;=^70705
 ;;^UTILITY(U,$J,358.3,3572,0)
 ;;=698.2^^31^304^1
 ;;^UTILITY(U,$J,358.3,3572,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3572,1,2,0)
 ;;=2^698.2
 ;;^UTILITY(U,$J,358.3,3572,1,5,0)
 ;;=5^Prurigo
 ;;^UTILITY(U,$J,358.3,3572,2)
 ;;=^100043
 ;;^UTILITY(U,$J,358.3,3573,0)
 ;;=132.1^^31^305^1
 ;;^UTILITY(U,$J,358.3,3573,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3573,1,2,0)
 ;;=2^132.1
 ;;^UTILITY(U,$J,358.3,3573,1,5,0)
 ;;=5^Pediculosis, Body
 ;;^UTILITY(U,$J,358.3,3573,2)
 ;;=^266961
 ;;^UTILITY(U,$J,358.3,3574,0)
 ;;=132.0^^31^305^2
 ;;^UTILITY(U,$J,358.3,3574,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3574,1,2,0)
 ;;=2^132.0
 ;;^UTILITY(U,$J,358.3,3574,1,5,0)
 ;;=5^Pediculosis, Head
 ;;^UTILITY(U,$J,358.3,3574,2)
 ;;=^266960
 ;;^UTILITY(U,$J,358.3,3575,0)
 ;;=132.2^^31^305^3
 ;;^UTILITY(U,$J,358.3,3575,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3575,1,2,0)
 ;;=2^132.2
 ;;^UTILITY(U,$J,358.3,3575,1,5,0)
 ;;=5^Pediculosis, Pubic
 ;;^UTILITY(U,$J,358.3,3575,2)
 ;;=^266962
 ;;^UTILITY(U,$J,358.3,3576,0)
 ;;=696.3^^31^306^1
 ;;^UTILITY(U,$J,358.3,3576,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3576,1,2,0)
 ;;=2^696.3
 ;;^UTILITY(U,$J,358.3,3576,1,5,0)
 ;;=5^Pityriasis Rosea
 ;;^UTILITY(U,$J,358.3,3576,2)
 ;;=^94726
 ;;^UTILITY(U,$J,358.3,3577,0)
 ;;=696.4^^31^306^2
 ;;^UTILITY(U,$J,358.3,3577,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3577,1,2,0)
 ;;=2^696.4
 ;;^UTILITY(U,$J,358.3,3577,1,5,0)
 ;;=5^Pityriasis Rubra Pilaris
 ;;^UTILITY(U,$J,358.3,3577,2)
 ;;=^94729
 ;;^UTILITY(U,$J,358.3,3578,0)
 ;;=698.0^^31^307^2
 ;;^UTILITY(U,$J,358.3,3578,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3578,1,2,0)
 ;;=2^698.0
 ;;^UTILITY(U,$J,358.3,3578,1,5,0)
 ;;=5^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,3578,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,3579,0)
 ;;=698.1^^31^307^3
 ;;^UTILITY(U,$J,358.3,3579,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3579,1,2,0)
 ;;=2^698.1
 ;;^UTILITY(U,$J,358.3,3579,1,5,0)
 ;;=5^Pruritus Vulvae
 ;;^UTILITY(U,$J,358.3,3579,2)
 ;;=^100071
 ;;^UTILITY(U,$J,358.3,3580,0)
 ;;=698.9^^31^307^1
 ;;^UTILITY(U,$J,358.3,3580,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3580,1,2,0)
 ;;=2^698.9
 ;;^UTILITY(U,$J,358.3,3580,1,5,0)
 ;;=5^Pruritic Disorder Unspecified
 ;;^UTILITY(U,$J,358.3,3580,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,3581,0)
 ;;=696.1^^31^308^1
 ;;^UTILITY(U,$J,358.3,3581,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3581,1,2,0)
 ;;=2^696.1
 ;;^UTILITY(U,$J,358.3,3581,1,5,0)
 ;;=5^Psoriasis
 ;;^UTILITY(U,$J,358.3,3581,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,3582,0)
 ;;=696.2^^31^308^2
 ;;^UTILITY(U,$J,358.3,3582,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,3582,1,2,0)
 ;;=2^696.2
 ;;^UTILITY(U,$J,358.3,3582,1,5,0)
 ;;=5^Parapsoriasis
